AMP hydrolysis reduction in blood plasma of breast cancer elderly patients after different treatments
- 5 June 2021
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 476 (10) , 3719-3727
Abstract
Adenine nucleotides are important signaling molecules that mediate biological functions in many conditions, including cancer. The enzymes CD39 and CD73 produce adenosine in the extracellular milieu that has a very important role in tumor development. This study aimed to evaluate nucleotide hydrolysis in the plasma blood of breast cancer elderly patients. In this prospective cohort study, we investigated the ectonucleotidases activity in breast cancer elderly patients, at the moment of diagnosis and after treatment. Control group consisted of elderly women without cancer diagnostic. The nucleotide hydrolysis assay was performed by the malachite green method and used ATP, ADP, or AMP as substrates. Paired t test or Wilcoxon rank-sum test was used. Our data showed that breast cancer patients presented high levels of ATP and AMP hydrolyses when compared to control group at the moment of diagnosis. When analyzing the differences between the samples at the time of diagnostic and 6 months after treatment, we observed a significant reduction on CD73 activity after all treatments used: surgery, chemotherapy, radiotherapy, or hormone therapy. The results with APCP, a specific CD73 inhibitor, showed that the AMP hydrolysis was inhibited in all conditions evaluated. We observed a diminished ADPase activity in the patients without metastasis when compared to metastatic breast cancer patients. The results showed that AMP hydrolysis was reduced in the blood plasma of breast cancer elderly patients after different treatments. This study strengthens the potential role of CD73 enzyme as a biomarker for breast cancer treatment response.Keywords
Funding Information
- FAPERGS (PPSUS-17/2551-0001455-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001, 001, 001, 001)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (310317/2018-5)
This publication has 41 references indexed in Scilit:
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancerProceedings of the National Academy of Sciences, 2013
- Cellular function and molecular structure of ecto-nucleotidasesPurinergic Signalling, 2012
- Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast CancerJAMA, 2012
- Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancerPurinergic Signalling, 2011
- Older Female Cancer Patients: Importance, Causes, and Consequences of UndertreatmentJournal of Clinical Oncology, 2007
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences, 2006
- Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93Journal of Clinical Oncology, 2006
- Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patientsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- A direct colorimetric assay for Ca2+-stimulated ATPase activityAnalytical Biochemistry, 1986
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976